Alzheimer's & Dementia (2025).
Tirzepatide benefits obese HFpEF patients with and without type 2 diabetes Tirzepatide, a diabetes drug sold under the brand names Zepbound and Mounjaro, is associated with significant improvements in patients with heart failure with preserved ejection fraction (HFpEF), according to new clinical data shared by Eli Lilly and Company
This means weeks of subtherapeutic dosing during each transition, periods where you are likely not getting adequate appetite suppression or weight loss benefits
Doll, H., Brown, S., Thurston, A
A glutathione activatable ion channel induces apoptosis in cancer cells by depleting intracellular glutathione levels
Turmeric's effects on weight are modest at best and only work as a supportive tool alongside a calorie deficit and physical activity